FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982462009> ?p ?o ?g. }

• W1982462009 endingPage "A163" @default.
• W1982462009 startingPage "A163" @default.
• W1982462009 abstract "<h3>Introduction</h3> There is increasing evidence for the use of probiotic bacteria in the treatment of irritable bowel syndrome (IBS). Most reports to date have been in patients with diarrhoea or bloating. The aim of this pilot study was to assess the efficacy of the probiotic VSL#3 in patients with constipation predominant IBS (IBS-C) and slow transit constipation (STC). <h3>Methods</h3> Patients were recruited from a tertiary referral functional bowel disorder clinic. All patients completed a 2 week stool diary, IBS symptom severity scores (IBS-SSS) and quality of life scores (PAC-SYM) at baseline. Patients received one sachet of open label VSL#3 containing a mixed freeze dried culture of 450 billion bacteria, twice a day for 12 weeks and then completed the questionnaires. <h3>Results</h3> 45 consecutive patients were invited to participate, but four declined as they had already tried OTC probiotics. 41 patients were studied (21 STC, 20 IBS-C). The mean age was 28.0, 85% were female, with a mean duration of symptoms of 9.9 years. Following treatment with VSL#3 there was a significant increase in mean number of spontaneous complete bowel motions (SCBM) per week see figure (1.0 (95% CI 0.5 to 1.4) p<0.0001). In addition there were significant improvements in quality of life scores (31.4 vs 22.9, p<0.0001) and IBS-SSS (305 vs 269, p<0.0001). Sub-group analysis demonstrated that in the IBS-C group there was a non-significant increase in SCBM/week (0.5 (95% CI −0.3 to 1.2)) but a significant reduction in PAC-SYM score (31.7 vs 22.7, p<0.0001) and IBS-SSS (322 vs 281, p=0.001. In the STC group there was a significant increase in the number of SCBM/week (1.5 (95% CI 0.9 to 2.0) p<0.0001) as well as improvements in PAC-SYM (31.0 vs 23.0, p=0.001) and IBS-SSS (290 vs 259, p=0.004). <h3>Conclusion</h3> This open-label pilot study suggests that VSL#3 improves symptoms and quality of life in women with IBS-C and STC. A larger randomised placebo controlled trial is warranted." @default.
• W1982462009 created "2016-06-24" @default.
• W1982462009 creator A5021779789 @default.
• W1982462009 creator A5049943066 @default.
• W1982462009 creator A5070556531 @default.
• W1982462009 date "2011-03-13" @default.
• W1982462009 modified "2023-10-18" @default.
• W1982462009 title "The probiotic VSL#3 increases scbm and reduces symptom severity scores in patients with functional constipation" @default.
• W1982462009 doi "https://doi.org/10.1136/gut.2011.239301.345" @default.
• W1982462009 hasPublicationYear "2011" @default.
• W1982462009 type Work @default.
• W1982462009 sameAs 1982462009 @default.
• W1982462009 citedByCount "0" @default.
• W1982462009 crossrefType "journal-article" @default.
• W1982462009 hasAuthorship W1982462009A5021779789 @default.
• W1982462009 hasAuthorship W1982462009A5049943066 @default.
• W1982462009 hasAuthorship W1982462009A5070556531 @default.
• W1982462009 hasBestOaLocation W19824620091 @default.
• W1982462009 hasConcept C126322002 @default.
• W1982462009 hasConcept C159110408 @default.
• W1982462009 hasConcept C2776956441 @default.
• W1982462009 hasConcept C2778271842 @default.
• W1982462009 hasConcept C2779642851 @default.
• W1982462009 hasConcept C2779802037 @default.
• W1982462009 hasConcept C2779951463 @default.
• W1982462009 hasConcept C2780255968 @default.
• W1982462009 hasConcept C2781112942 @default.
• W1982462009 hasConcept C523546767 @default.
• W1982462009 hasConcept C54355233 @default.
• W1982462009 hasConcept C71924100 @default.
• W1982462009 hasConcept C86803240 @default.
• W1982462009 hasConcept C90924648 @default.
• W1982462009 hasConceptScore W1982462009C126322002 @default.
• W1982462009 hasConceptScore W1982462009C159110408 @default.
• W1982462009 hasConceptScore W1982462009C2776956441 @default.
• W1982462009 hasConceptScore W1982462009C2778271842 @default.
• W1982462009 hasConceptScore W1982462009C2779642851 @default.
• W1982462009 hasConceptScore W1982462009C2779802037 @default.
• W1982462009 hasConceptScore W1982462009C2779951463 @default.
• W1982462009 hasConceptScore W1982462009C2780255968 @default.
• W1982462009 hasConceptScore W1982462009C2781112942 @default.
• W1982462009 hasConceptScore W1982462009C523546767 @default.
• W1982462009 hasConceptScore W1982462009C54355233 @default.
• W1982462009 hasConceptScore W1982462009C71924100 @default.
• W1982462009 hasConceptScore W1982462009C86803240 @default.
• W1982462009 hasConceptScore W1982462009C90924648 @default.
• W1982462009 hasIssue "Suppl 1" @default.
• W1982462009 hasLocation W19824620091 @default.
• W1982462009 hasOpenAccess W1982462009 @default.
• W1982462009 hasPrimaryLocation W19824620091 @default.
• W1982462009 hasRelatedWork W2057226727 @default.
• W1982462009 hasRelatedWork W2058150145 @default.
• W1982462009 hasRelatedWork W2086642698 @default.
• W1982462009 hasRelatedWork W2098294301 @default.
• W1982462009 hasRelatedWork W2115907282 @default.
• W1982462009 hasRelatedWork W2242699736 @default.
• W1982462009 hasRelatedWork W2386306817 @default.
• W1982462009 hasRelatedWork W2428679765 @default.
• W1982462009 hasRelatedWork W2566065710 @default.
• W1982462009 hasRelatedWork W3032753457 @default.
• W1982462009 hasVolume "60" @default.
• W1982462009 isParatext "false" @default.
• W1982462009 isRetracted "false" @default.
• W1982462009 magId "1982462009" @default.
• W1982462009 workType "article" @default.